Patent · US Active

Modifications for antisense compounds

US10087445B2 · kind B2 · utility

0Cited by
92References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 23, 2016
Grant dateOct 2, 2018
Priority date
Expiry dateNov 23, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention pertains to modifications for antisense oligonucleotides, wherein the modifications are used to improve stability and provide protection from nuclease degradation. The modifications could also be incorporated into double-stranded nucleic acids, such as synthetic siRNAs and miRNAs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.